Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01577251 · ClinicalTrials.gov registry record

The Radiation Oncology Registry and Biosample Repository

A clinical trial of Neoplasia, sponsored by Abramson Cancer Center at Penn Medicine.

Recruiting
Registry status
8,000
Enrollment target
4
Study locations

NCT01577251: Recruiting study of Neoplasia, sponsored by Abramson Cancer Center at Penn Medicine.

NCT01577251 is a study of Neoplasia that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 8,000 participants. The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01577251, a study of Neoplasia, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.

RECRUITING
Registry status
8,000 participants
Enrollment target
4
Study locations

Study Summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Conditions Studied

Study Locations (4)

New Jersey

  • Virtua Samson Cancer Center - Moorestown
  • Virtua Health & Wellness Center - Voorhees Township

Pennsylvania

  • Lancaster General Hospital - Lancaster
  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 8,000 participants
Start Date 2008-06
Est. Completion 2030-12

What NCT01577251 shows while recruiting

NCT01577251 is an observational study that tracks outcomes without assigning an intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Neoplasia appearing as the primary indexed condition, and to 0 interventions.

NCT01577251 reports a single indexed study location in New Jersey, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01577251 about?

NCT01577251 is a clinical study titled "The Radiation Oncology Registry and Biosample Repository". The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

What is the current status of trial NCT01577251?

This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2008-06. Estimated completion is 2030-12.

What conditions does trial NCT01577251 study?

This clinical trial studies the following conditions: Neoplasia.

Who is sponsoring clinical trial NCT01577251?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01577251 being conducted?

This trial has 4 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00539162 · 8,000 participants · NA

    Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

  • NCT00898638 · 8,000 participants

    Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

  • NCT02240862 · 8,000 participants

    The CREST-2 Registry

  • NCT03072927 · 8,000 participants

    MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01577251, the US trial registry maintained by the National Library of Medicine. NCT01577251 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.